ALDERON BIOSCIENCES, INC.

Medtech · Defunct

Advanced blood lead diagnostic test using an 8-sensor platform with proprietary reagent for measuring blood lead levels from a single drop of blood

Grants
$1.6M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Point-of-Care Tests for Blood Lead Levels in Children$453,545
Federal grantDepartment of Health and Human Services · Phase II · New Test System for Blood Lead Levels in Children$554,446
Federal grantDepartment of Health and Human Services · Phase II · New Test System for Blood Lead Levels in Children$554,446
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1668Wisdom.io Inc.—$50K
1669CELLECTGEN, INC.——
1670ALTRUMED LLC——
1671ALDERON BIOSCIENCES, INC.——
1672MULTIFUNCTIONAL IMAGING, LLC——
1673ISTOSVISIO INC——
1674LASE INNOVATION INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.